M Kathleen Behrens Igm Biosciences, Inc. (IGMS) insider trading activity

M Kathleen Behrens is of IGM Biosciences, Inc.. Currently has a direct ownership of 13,124 shares of IGMS, which is worth approximately $161,425. The most recent transaction as insider was on Jun 28, 2024, when has been sold 3,078 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K

30.64% 3M change

144.49% 12M change

Total Value Held $161,425

M KATHLEEN BEHRENS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	BUY Grant, award, or other acquisition	-	3,078 Added 19.0%	13,124 Common Stock
Mar 29 2024	BUY Grant, award, or other acquisition	-	3,078 Added 23.45%	10,046 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	800 Added 10.3%	6,968 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	800 Added 11.48%	6,168 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	800 Added 12.97%	5,368 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	800 Added 14.9%	4,568 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	-	374 Added 9.03%	3,768 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	374 Added 9.93%	3,394 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	374 Added 11.02%	3,020 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	374 Added 12.38%	2,646 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	211 Added 8.5%	2,272 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	211 Added 9.29%	2,061 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	211 Added 10.24%	1,850 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	211 Added 0.22%	94,139 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	-	357 Added 0.38%	93,928 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	357 Added 0.38%	93,571 Common Stock

Also insider at

MDXG

MIMEDX GROUP, INC. Healthcare

Director

SRPT

Sarepta Therapeutics, Inc. Healthcare

MKB